2019-04-29T09:41:16-05:00 2018-06-30 GRANT THORNTON LLP 75 State Street Boston MA 02109 990 2017-07-01 042104230 Forsyth Dental Infirmary for Children % WANDA CORDOVA FORS 6172625200 245 First Street Cambridge MA 02142 WANDA CORDOVA CFO 6172625200 2019-04-29 true Daniel Romano P00504182 6177237900 209.220.136.124 04586620191195000003 2019-04-29 P C0092A61B473193CE28A43111BDA0C877506765C C0092A61B473193CE28A43111BDA0C877506765C 2017 2019-02-21 02:37:17Z The Forsyth Institute WENYUAN SHI 245 First Street Cambridge MA 02142 18298406 false X www.forsyth.org X 1910 MA TO IMPROVE ORAL AND OVERALL HEALTH THROUGH COMBINATION OF INNOVATIVE RESEARCH AND COMMUNITY OUTREACH BY ACCELERATING THE DELIVERY OF WELLNESS SOLUTIONS INTO THE REAL WORLD. 20 19 151 90 700053 -338154 16616306 11497146 2844705 3620403 1924391 2687455 135321 387635 21520723 18192639 2222176 1707927 0 0 13588241 12156573 0 0 241637 11571133 18421760 27381550 32286260 -5860827 -14093621 73631229 61681227 9619272 9748235 64011957 51932992 X THE FORSYTH INSTITUTE WAS FOUNDED TO PROVIDE FREE DENTAL CARE TO BOSTON'S POOREST CHILDREN. IT WAS QUICKLY DETERMINED THAT TREATING THE RAVAGES OF DENTAL DISEASE (SCHEDULE O) false false 25098992 1707927 3620403 OVER THE PAST 100 YEARS, FORSYTH HAS EVOLVED INTO AN INNOVATIVE CENTER FOR BIOMEDICAL RESEARCH. MANY OF FORSYTH'S SCIENTISTS USE THE MOUTH AS A PORTAL TO LEARN MORE ABOUT THE BODY; AND ARE EXAMINING HOW BONE LOSS OCCURS AND HOW INFLAMMATION CONTRIBUTES TO SYSTEMIC DISEASES SUCH AS DIABETES AND HEART DISEASE. OTHERS ARE INVESTIGATING THE ROLES THAT BACTERIA IN AND ON THE HUMAN BODY (OUR MICROBIOME) PLAY IN HEALTH AND DISEASE - FROM CAVITIES TO PNEUMONIA. THE INSTITUTE'S FOUNDING PUBLIC HEALTH MISSION REMAINS STRONG THROUGH THE FORSYTHKIDS PROGRAM, A NOVEL MOBILE SERVICE DELIVERING DENTAL CARE TO THOUSANDS OF UNDERSERVED CHILDREN ANNUALLY. 25098992 true true false true false false false false false true true true false false true true false true false false true true false false true false false true false true false false false false false false false false false false false false false true true true false false true 34 0 true 151 true true true false false false false false false false false false X 20 19 false false false false false false false true true false false true true true true true true true true true true MA X X WANDA CORDOVA 6178928367 245 FIRST STREET Cambridge MA 02142 MR PETER NESSEN Chairman of the Board 4.0 0.0 X X 0 0 0 DR DAVID W ELLIS Vice Chair 1.0 0.0 X X 0 0 0 MR RICHARD ANDERS Director 1.0 0.0 X 0 0 0 MS JANICE BOURQUE Director 1.0 0.0 X 0 0 0 MS ELYSE D CHERRY Director 1.0 0.0 X 0 0 0 MS CATHERINE D'AMATO Director 1.0 0.0 X 0 0 0 DR BRUCE DONOFF Director 1.0 0.0 X 0 0 0 MR DAI FENG Director 1.0 0.0 X 0 0 0 DR JOHN FICARELLI Director 1.0 0.0 X 0 0 0 MS ROSALEE HERMENS Director 1.0 0.0 X 0 0 0 MS KARLA L JARVIS Director 1.0 0.0 X 0 0 0 MS JANET KELLY Director 1.0 0.0 X 0 0 0 MR STEVEN KESS Director 1.0 0.0 X 0 0 0 MR MICHAEL MONOPOLI Director 1.0 0.0 X 0 0 0 MR JOHN M PLUKAS Director 1.0 0.0 X 0 0 0 MR J BRIAN POTTS Director 1.0 0.0 X 0 0 0 MR WALTER M PRESSEY Director 1.0 0.0 X 0 0 0 MS ROBYN REDFIELD Director 1.0 0.0 X 0 0 0 MS NANCY ROSENZWEIG Director (Thru 12/17) 1.0 0.0 X 0 0 0 DR ANTHONY R VOLPE Director 1.0 0.0 X 0 0 0 DR WENYUAN SHI Pres,CEO,&Chief Scientific Off 45.0 0.0 X X 146870 0 7745 MS DIANE MACDONALD COO, SEC., INT. CEO(Thru 1/18) 45.0 0.0 X X 355506 0 47049 MS WANDA CORDOVA CFO & TREASURER 45.0 0.0 X 179671 0 34347 MS GENEVIEVE HOLMES CHIEF Project OFFICER & SEC 45.0 0.0 X 64013 0 5816 DR THOMAS E VAN DYKE VP CLINICAL & TRANS. RES. 45.0 0.0 X 311629 0 23226 DR PHILIP STASHENKO Senior Scientist 45.0 0.0 X 258609 0 35348 DR PRAMOD M SOPARKAR Senior Scientist 45.0 0.0 X 219025 0 36144 DR FLOYD DEWHIRST Senior Scientist 45.0 0.0 X 198051 0 44807 DR BRUCE PASTER Senior Scientist 45.0 0.0 X 197905 0 17524 DR MARGARET DUNCAN Senior Scientist 45.0 0.0 X 187753 0 16650 2119032 0 268656 25 false true false Back Bay Life Science Advisors LLC 545 Boylston Street BOSTON MA 02116 Consulting 181611 Foley Hoag LLP 155 Seaport Boulevard BOSTON MA 02210 Legal 109467 Matter Communications Inc 50 Water Street NEWBURYPORT MA 01950 PUBLIC RELATIONS 100624 3 52205 10376643 1068298 11497146 RESEARCH 541700 1582817 1582817 FESC RESEARCH CENTER 541700 1141800 1141800 DENTAL SERVICES 621400 895786 195733 700053 3620403 1063100 1063100 0 0 0 0 0 1602355 22000 1602355 22000 1624355 1624355 60290 52205 105767 -45477 -45477 0 0 0 0 0 0 INSURANCE CLAIM PAYMENT 900099 325022 325022 MISCELLANEOUS INCOME 900099 108090 108090 433112 18192639 2920350 700053 3075090 1579056 1579056 0 128871 128871 0 1241617 210134 1013668 17815 0 8127697 5894459 2147338 85900 634630 449723 176784 8123 1522852 953098 553311 16443 629777 409489 213117 7171 0 274844 26045 248799 95000 95000 68133 66000 2133 0 434514 434514 939252 283373 633292 22587 66528 704 65794 30 0 77780 12717 57919 7144 0 4830563 4545353 259282 25928 161377 74976 57200 29201 0 63828 2508 56724 4596 11619 11619 0 3022506 2965039 52243 5224 210689 17717 192972 BAD DEBT 6276700 6276700 SUPPLIES 1059410 896868 161024 1518 OTHER EXPENSES 829017 306162 512898 9957 32286260 25098992 6945631 241637 576548 914752 305000 305000 43000 0 9021679 3435250 0 0 0 0 0 0 0 0 177165 237496 29948124 17438350 14230870 12509774 0 0 49276967 44278955 0 0 0 0 0 0 73631229 61681227 2121508 2461533 0 0 440700 652310 0 0 0 0 0 0 0 0 2000000 2000000 5057064 4634392 9619272 9748235 X 14571031 7588886 48940926 43844106 500000 500000 64011957 51932992 73631229 61681227 -14093621 2014656 X false true X true true true X 16861415 18828815 15255665 16616306 11497146 79059347 5589963 4356952 6921017 2190176 2920350 21978458 0 0 0 22451378 23185767 22176682 18806482 14417496 101037805 32000 15000 57075 37585 32050 173710 746234 1558289 2304523 32000 15000 57075 783819 1590339 2478233 98559572 719204 1167224 996363 661633 1063100 4607524 0 719204 1167224 996363 661633 1063100 4607524 0 158342 248556 173513 184461 493402 1258274 23328924 24601547 23346558 19652576 15973998 106903603 0.92195 0.94483 0.04310 0.04182 X 68133 68133 31783613 31851746 1000000 250000 false 1000000 1000000 1000000 1000000 4000000 6000000 101114 13384 12060 68133 194691 250000 250000 250000 250000 1000000 1500000 LOBBYING ACTIVITY EXPENSES INCLUDE A CONTRACT WITH A LOBBYING FIRM FOR ASSISTANCE WITH STATE GRANT LOBBYING. THIS ARRANGEMENT BEGAN IN MAY 2017. ADDITIONALLY, FORSYTH BELONGS TO A MEMBERSHIP ORGANIZATION WHICH ENGAGES IN LOBBYING ACTIVITIES. A PORTION OF THE DUES PAID ARE SPECIFICALLY IDENTIFIED AS LOBBYING EXPENSES. 49276967 4245291 9243303 44278955 50258923 5209122 6191078 49276967 58466801 -1362958 6844920 50258923 61378494 280367 3192060 58466801 55764244 8934086 3319836 61378494 0.01000 0.99000 true false 0 16774746 8277367 8497379 0 11703049 8588106 3114943 0 1470329 572877 897452 12509774 BENEFICIAL INTEREST IN TRUST 44278955 F 44278955 0 DEFERRED RENT 4634392 4634392 X 19772781 2014656 2014656 17758125 434514 434514 18192639 31851746 31851746 434514 434514 32286260 INTENDED USES OF ENDOWMENT FUNDS SCHEDULE D, PART V, LINE 4 TO SUPPORT THE CHARITABLE MISSION OF THE FORSYTH DENTAL INFIRMARY FOR CHILDREN. ASC 740 FOOTNOTE SCHEDULE D, PART X, LINE 2 THE INSTITUTE FOLLOWS GUIDANCE THAT CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING ISSUES RELATING TO FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT. THIS GUIDANCE PROVIDES THAT THE TAX EFFECTS FROM AN UNCERTAIN TAX POSITION CAN ONLY BE RECOGNIZED IN THE FINANCIAL STATEMENTS IF THE POSITION IS "MORE-LIKELY-THAN-NOT" TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. THE ASSESSMENT OF THE TAX POSITION IS BASED SOLELY ON THE TECHNICAL MERITS OF THE POSITION, WITHOUT REGARD TO THE LIKELIHOOD THAT THE TAX POSITION MAY BE CHALLENGED. THE INSTITUTE (AND FORSYTH INTERNATIONAL) ARE ORGANIZATIONS DESCRIBED IN SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE, AS AMENDED (THE "CODE"), AND ARE GENERALLY EXEMPT FROM INCOME TAXES PURSUANT TO SECTION 501(A) OF THE CODE. THE INSTITUTE IS RESPONSIBLE FOR THE MAINTENANCE OF ITS TAX-EXEMPT STATUS; IDENTIFYING AND REPORTING UNRELATED INCOME; DETERMINING ITS FILING AND TAX OBLIGATIONS IN JURISDICTIONS FOR WHICH IT HAS NEXUS; AND IDENTIFYING AND EVALUATING OTHER MATTERS THAT MAY BE CONSIDERED TAX POSITIONS. THE INSTITUTE HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS. true Middle East and North Africa Program Services Research Travel 1743 Europe (Including Iceland and Greenland) Grantmaking Research 128870 130613 130613 Europe (Including Iceland and Greenland) Subaward 96000 CHECK Europe (Including Iceland and Greenland) Subaward 32870 CHECK 2 0 false false false false false true SCHEDULE F, PART I, LINE 2 THE INSTITUTE ASSIGNS RESPONSIBILITY FOR MONITORING THE USE OF GRANT FUNDS OUTSIDE OF THE UNITED STATES TO ITS OFFICE OF SPONSORED RESEARCH. THIS OFFICE MONITORS ALL GRANT MAKING ACTIVITY INCLUDING ALL APPLICABLE COMPLIANCE REGULATIONS. MONITORING INCLUDES PERIODIC REVIEWS OF BUDGET TO ACTUAL REPORTS BY BOTH THE OFFICE OF SPONSORED RESEARCH AND THE PRINCIPAL INVESTIGATOR TO ENSURE FUNDS ARE USED ACCORDING TO THE AGREEMENT. EXPENSES ARE ACCOUNTED FOR ON AN ACCRUAL BASIS. MA TASTE & TOAST 112495 52205 60290 920 104847 0 112495 52205 60290 920 104847 105767 -45477 true Brigham & Women's Hospital 77 Louis Paster Avenue Boston MA 02115 042312909 501(c)(3) 110526 Program Support Boston University 1 Silber Way Boston MA 02215 042103547 501(c)(3) 148949 Program Support Duke University 2200 West Main Street Durham NC 27705 560532129 501(c)(3) 23856 Program Support Marine Biological Laboratory 7 Mbl Street Woods Hole MA 02543 042104690 501(c)(3) 52004 Program Support Massachusetts General Hospital 210 Longwood Avenue Boston MA 02115 042697983 501(c)(3) 154938 Program Support Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge MA 02139 042103594 501(c)(3) 308294 Program Support Northwestern University 633 Clark Street Evaston IL 60208 362167817 501(c)(3) 36627 Program Support Stanford University 3160 Porter Drive Palo Alto CA 94304 941156365 501(c)(3) 105003 Program Support Tufts Medical Center 800 Washington Street Boston MA 02111 043400617 501(c)(3) 342664 Program Support University of California 1855 Folsom Street San Fransisco CA 94143 946036493 GOV'T 37158 Program Support The University of Florida Board of Trustees PO Box 113001 Gainesville FL 32611 596002052 GOV'T 39807 Program Support University of Pittsburgh 3109 Cathedral of Learning Pittsburgh PA 15260 250965591 GOV'T 43223 Program Support University of Washington 4300 Roosevelt Way NE Seattle WA 98195 916001537 GOV'T 166701 Program Support Vanderbilt University Medical Center 23rd Avenue South at Pierce Nashville TN 37232 620476822 501(c)(3) 10810 Program Support 14 ORGANIZATION'S PROCEDURES FOR MONITORING THE USE OF GRANTS IN THE U.S. SCHEDULE I, PART I, LINE 2 THE INYTITUTE ASSIGNS RESPONSIBILITY FOR MONITORING THE USE OF GRANT FUNDS TO ITS OFFICE OF SPONSORED RESEARCH. THIS OFFICE MONITORS ALL GRANT MAKING ACTIVITY INCLUDING ALL APPLICABLE COMPLIANCE REGULATIONS. MONITORING INCLUDES PERIODIC REVIEWS OF BUDGET TO ACTUAL REPORTS BY BOTH THE OFFICE OF SPONSORED RESEARCH AND THE PRINCIPAL INVESTIGATOR TO ENSURE FUNDS ARE USED ACCORDING TO THE AGREEMENT. EXPENSES ARE ACCOUNTED FOR ON AN ACCRUAL BASIS. X false true X X X X X X false false false false false false false false false DR WENYUAN SHI Pres,CEO,&Chief Scientific Off 123156 0 0 0 23714 0 5455 0 2290 0 154615 0 0 0 MS DIANE MACDONALD COO, SEC., INT. CEO(Thru 1/18) 352152 0 0 0 3354 0 22831 0 24218 0 402555 0 0 0 MS WANDA CORDOVA CFO & TREASURER 178465 0 0 0 1206 0 17550 0 16797 0 214018 0 0 0 DR THOMAS E VAN DYKE VP CLINICAL & TRANS. RES. 301989 0 0 0 9640 0 22956 0 270 0 334855 0 0 0 DR PHILIP STASHENKO Senior Scientist 246453 0 0 0 12156 0 19970 0 15378 0 293957 0 0 0 DR PRAMOD M SOPARKAR Senior Scientist 209434 0 0 0 9591 0 19669 0 16475 0 255169 0 0 0 DR FLOYD DEWHIRST Senior Scientist 192977 0 0 0 5074 0 18463 0 26344 0 242858 0 0 0 DR BRUCE PASTER Senior Scientist 194708 0 0 0 3197 0 17524 0 0 0 215429 0 0 0 DR MARGARET DUNCAN Senior Scientist 183620 0 0 0 4133 0 16650 0 0 0 204403 0 0 0 HOUSING ALLOWANCE POLICY SCHEDULE J, PART I, LINE 1B DR. WENYUAN SHI WAS PROVIDED A RELOCATION REIMBURSEMENT OF $15,000 AND A HOUSING SUBSIDY BENEFIT OF $8,000 THAT IS REPORTED AS PART OF OTHER REPORTABLE COMPENSATION. NON-FIXED PAYMENTS SCHEDULE J, PART I, LINE 7 ON AN ANNUAL BASIS, ANY BONUS AWARDED TO THE CEO IS SUBJECT TO REVIEW AND APPROVAL BY THE BOARD OF DIRECTORS PRIOR TO PAYMENT. BONUS PAYMENTS TO OTHER KEY EMPLOYEES OR HIGHEST COMPENSATED EMPLOYEES ARE SUBJECT TO REVIEW AND APPROVAL BY THE CEO AND CFO. BONUSES ARE BASED ON INDIVIDUAL PERFORMANCE AND ANY AMOUNTS AWARDED ARE REPORTED ON SCHEDULE J, PART II, COLUMN (B)(II). NO BONUSES WERE AWARDED IN 2017. MISSION STATEMENT (CONTINUED) FORM 990, PART III, LINE 1 WAS SIMPLY IMPOSSIBLE GIVEN THE LIMITATIONS IN KNOWLEDGE OF THEIR CAUSES AND BEST MEANS OF PREVENTION - THUS BEGAN AN EXCITING JOURNEY OF SCIENTIFIC DISCOVERY. IN THE DECADES FOLLOWING, OUR RESEARCH HELPED TO TRANSFORM THE WAY THE WORLD UNDERSTANDS ORAL HEALTH. FORSYTH SCIENTISTS HAVE DEMONSTRATED DISTINCT CONNECTIONS BETWEEN ORAL DISEASES AND HEALTH CHALLENGES LIKE HEART DISEASE, DIABETES, AND EVEN CERTAIN CANCERS, AND ARE TACKLING OTHER GLOBAL INFECTIOUS DISEASES. WE HAVE ASSEMBLED A WORLD CLASS, MULTIDISCIPLINARY SCIENTIFIC TEAM CAPABLE OF SYSTEM-WIDE APPROACHES TO BIOMEDICAL INNOVATION WITH THE POTENTIAL FOR PROFOUND IMPACT. BECAUSE THE FORSYTH TEAM COMBINES THE BEST KNOWLEDGE OF ORAL AND SYSTEMIC DISEASES WITH A RELENTLESS DRIVE TO ASK - AND ANSWER - NEW QUESTIONS, WE HAVE MADE MANY PARADIGM SETTING SCIENTIFIC AND MEDICAL ADVANCES. AS AN INDEPENDENT RESEARCH INSTITUTE, WE HAVE THE FREEDOM TO FOLLOW OUR SCIENCE WHEREVER IT LEADS, AND TO COLLABORATE WITH A BROAD SPECTRUM OF STAKEHOLDERS - OTHER RESEARCH ORGANIZATIONS, INDUSTRY, PRACTICING PROFESSIONALS, PUBLIC LEADERS, AND PATIENTS - TO MEET OUR SHARED GOALS. IN THE YEARS AHEAD, THE FORSYTH WILL CONTINUE TO LEVERAGE ITS UNIQUE KNOWLEDGE OF ORAL AND ASSOCIATED SYSTEMIC DISEASES TO ELUCIDATE NEW BIOMEDICAL INSIGHTS, AND TO FIND THE BEST WAYS - UNFETTERED BY CONVENTION-TO HELP BILLIONS LIVE HEALTHIER LIVES. FORM 990 REVIEW PROCESS FORM 990, PART VI, SECTION B, LINE 11B THE RETURN WAS PREPARED BY TAX ADVISORS FROM A NATIONAL ACCOUNTING FIRM WITH INFORMATION PROVIDED BY MANAGEMENT. THE DRAFT FORM 990 IS REVIEWED BY THE CEO, CFO, AND THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS. IT IS THEN DISTRIBUTED TO EACH MEMBER OF THE BOARD OF DIRECTORS FOR REVIEW BEFORE FILING. CONFLICT OF INTEREST POLICY MONITORING & ENFORCEMENT FORM 990, PART VI, SECTION B, LINE 12C FORSYTH'S CONFLICT OF INTEREST POLICY APPLIES TO FORSYTH'S BOARD MEMBERS, OFFICERS, ADMINISTRATORS, AND RESEARCH EMPLOYEES AND WAS ESTABLISHED TO PROTECT THE INTEREST OF THE INSTITUTE - THE DESIGN, CONDUCT, OR REPORTING OF OPERATIONS OR RESEARCH. CONSISTENT WITH THE POLICY, OFFICERS, ADMINISTRATORS, RESEARCH STAFF EMPLOYEES AND BOARD MEMBERS ARE REQUIRED TO COMPLETE AN ANNUAL CONFLICT OF INTEREST DISCLOSURE FORM. TO ACCOMPLISH THIS OBJECTIVE, THIS POLICY ESTABLISHES A DISCLOSURE SYSTEM WHEREBY POTENTIAL CONFLICT SITUATIONS WILL BE IDENTIFIED, REVIEWED AND ADDRESSED. FORSYTH OFFICERS, ADMINISTRATORS, AND RESEARCH EMPLOYEES - FORSYTH'S CHIEF GENERAL COUNSEL IS THE INSTITUTIONAL OFFICIAL WHO IS RESPONSIBLE FOR DISSEMINATING THE CONFLICT OF INTEREST POLICY AND COLLECTING SIGNED DISCLOSURE STATEMENTS WHEN THE EMPLOYEES ARE FIRST HIRED AND ANNUALLY THEREAFTER. THE RESOLUTION OF ANY CONFLICT OR PERCEIVED CONFLICT IS IDENTIFIED BY THE INSTITUTIONAL OFFICIAL, IN CONSULTATION WITH FORSYTH'S CONFLICT OF INTEREST COMMITTEE. FORSYTH BOARD MEMBERS - THE SECRETARY OF THE BOARD IS RESPONSIBLE FOR DISSEMINATING THE CONFLICT OF INTEREST POLICY AND COLLECTING SIGNED DISCLOSURE STATEMENTS FROM BOARD MEMBERS AT THE TIME THEY ARE APPOINTED AND ANNUALLY THEREAFTER. THE RESOLUTION OF ANY CONFLICT OR PERCEIVED CONFLICT IS IDENTIFIED BY THE SECRETARY IN CONSULTATION WITH THE CHAIRMAN OF FORSYTH'S BOARD OF DIRECTORS. AS A VOTING BOARD MEMBER, THE CEO DOES NOT VOTE ON AND IS RECUSED WHEN A CONFLICT OF INTEREST ARISES. PROCESS FOR DETERMINING COMPENSATION FORM 990, PART VI, SECTION B, LINES 15A AND 15B CEO COMPENSATION IS REVIEWED AND APPROVED ANNUALLY BY THE INDEPENDENT BOARD OF DIRECTORS. COMPARABLE COMPENSATION DATA AND FORM 990 DATA FROM OTHER ORGANIZATIONS ARE UTILIZED FOR THE REVIEW OF CEO COMPENSATION. THE CEO REVIEWS AND APPROVES COMPENSATION FOR THE EXECUTIVE MANAGEMENT, USING MARKET SURVEYS AND FORM 990 DATA FOR OTHER SIMILAR ORGANIZATIONS. THESE DECISIONS ARE REVIEWED BY THE BOARD OF DIRECTORS. ANNUALLY, FORSYTH PARTICIPATES IN A COMPENSATION SURVEY THAT INCLUDES COMPARATIVE DATA OF SIMILAR ORGANIZATIONS. THESE ANALYSES ARE UTILIZED IN THE REVIEW OF THE CEO AND EXECUTIVE MANAGEMENT'S COMPENSATION. BOTH THE DELIBERATION AND DECISION PROCESS FOR DETERMINING COMPENSATION OF THE CEO AND EXECUTIVE MANAGEMENT IS CONTEMPORANEOUSLY DOCUMENTED. HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC FORM 990, PART VI, SECTION C, LINE 19 THE FORSYTH INSTITUTE MAKES ITS GOVERNING DOCUMENTS, WRITTEN POLICIES AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. THESE ITEMS ARE AVAILABLE UPON REQUEST. Forsyth International Inc 245 FIRST STREET CAMBRIDGE MA 02142 043443294 DENTAL CARE MA 501(C)(3) 09 FORSYTH true Beneficial Interest Trust Trust MA Forsyth Trust 9343303 0 1.00000 false false false false false false false false false false false false false false false false false false false false